Trials / Terminated
TerminatedNCT00070317
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
Lymphatic Mapping and Sentinel Node Identification in Patients With Stage1B1 Cervical Carcinoma
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- Gynecologic Oncology Group · Network
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This clinical trial is studying how well lymph node mapping and sentinel lymph node identification work in finding lymph node metastases in patients with stage IB1 cervical cancer. Diagnostic procedures, such as lymph node mapping and sentinel lymph node identification, performed before and during surgery, may improve the ability to detect lymph node metastases in patients who have cervical cancer.
Detailed description
OBJECTIVES: I. Determine the sensitivity of the sentinel lymph node in the determination of lymph node metastases, using preoperative or intraoperative lymphatic mapping, in patients with stage IB1 cervical cancer. II. Determine the false-negative predictive value of the sentinel lymph node in the determination of lymph node metastases in these patients. OUTLINE: This is a multicenter study. Patients receive radiolabeled technetium Tc 99m sulfur colloid injected around the tumor 6 hours prior to or after induction of anesthesia right before surgery. Patients then undergo radical hysterectomy and complete pelvic and low para-aortic lymphadenectomy. Intraoperatively, patients undergo lymphatic mapping and sentinel lymph node identification using isosulfan blue or methylene blue injected at 4 locations in the cervix and a hand-held gamma counter.
Conditions
- Cervical Adenocarcinoma
- Cervical Adenosquamous Carcinoma
- Cervical Squamous Cell Carcinoma
- Stage I Cervical Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Isosulfan Blue | Undergo lymphangiography using isosulfan blue or methylene blue |
| PROCEDURE | Lymph Node Mapping | Undergo lymphatic mapping |
| PROCEDURE | Lymphangiography | Undergo lymphangiography using isosulfan blue or methylene blue |
| DRUG | Methylene Blue | Undergo lymphangiography using isosulfan blue or methylene blue |
| PROCEDURE | Radionuclide Imaging | Undergo radionuclide imaging with technetium Tc 99m sulfur colloid |
| PROCEDURE | Sentinel Lymph Node Biopsy | Undergo complete pelvic and low para-aortic lymphadenectomy |
| RADIATION | Technetium Tc-99m Sulfur Colloid | Undergo radionuclide imaging with technetium Tc 99m sulfur colloid |
| PROCEDURE | Therapeutic Conventional Surgery | Undergo radical hysterectomy |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2003-10-07
- Last updated
- 2017-11-06
- Results posted
- 2017-10-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00070317. Inclusion in this directory is not an endorsement.